Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Targeted Protein Degraders: Transforming Oral Therapeutics
CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.
Podcast — Strategic Site Identification: A Proven Approach
Watch our new podcast to discover Altasciences' unique process for identifying and selecting the right clinical sites for your unique project.
Building Recruitment Into Early-Phase Trial Design
Successful recruitment starts with smart study design. Early recruitment insight improves feasibility, supports realistic timelines, and reduces enrollment risk.
Why Should Site Agility Be Your Next Competitive Advantage?
Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.

Why Early Medical Assessment Matters In Clinical Trials
1/6/2026

Early medical assessment reduces risk, improves patient selection, and avoids trial delays. Learn how starting early boosts compliance, speeds timelines, and protects participants and results.
No-Frills, High-Impact Vendor Oversight: 4 Principles That Never Let Me Down
8/13/2026

Discover a streamlined four-pillar framework for vendor oversight. Learn how tracking essential KPIs across time, budget, quality, and relationships drives accountability in clinical operations.
Driving Greater Efficiency Through Modular Trial Design
6/27/2025

As clinical trials grow more complex and patient-centric, traditional site-based models are proving insufficient and prompting the rise of modular, technology-enabled delivery strategies.
The Silent Saboteurs: Why Rater Drift And Site Unpreparedness Cost CNS Trials More
3/25/2026

High-end technology cannot fix poor rater preparation or complex patient needs. True data integrity requires bridging the gap between digital platforms and the reality of clinical implementation.
2025 Clinical Trial Payment Tax Implications Explained
10/8/2025

Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.

Quality Assurance Services

The quality assurance (QA) team ensures the highest standards from pre-clinical to market by focusing on operational quality control, quickly identifying potential issues, and implementing necessary changes.
Autoinjector, Pen, And Prefilled Syringe Capabilities

Flexible, scalable capabilities for autoinjectors, pens, and prefilled syringes — ranging from manual to fully automated — streamlining and simplifying your biologic drug development supply chain.
Full -Service NeuroScience CRO

Explore how dedicated brain and nervous system research support, deep disease expertise, and operational rigor can optimize your clinical trial's success.
Accelerate Participant Enrollment With Better Site Matches

With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.
Getting Biotechs GlobalReady

Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.